News & Information
Webcast Dec. 11th at 6pm ET: The INs and OUTs of Clinical TrialsHow inclusion and exclusion criteria affect patients participation in clinical trials. Facebook Live
A Small Number Of Men With Prostate Cancer Are Super Responders to ImmunotheraphyResults from a new clinical trial have shown that some men with advanced prostate cancer can live for at least two more years on immunotherapy after exhausting all other treatment options...
Psychosocial Concerns Common After Prostate Cancer TreatmentPsychosocial problems that adversely affect quality of life are common among men after receiving treatment for prostate cancer, and they need help....
Men Over 40 With BRCA2 Mutations Must Get Prostate Cancer Screening, Experts SayResearchers have called for immediate action to recommend screening for prostate cancer for men with BRCA2 mutations over the age of 40.
Increasing Diversity in Clinical Trials
Clinical trials lead to the approval of new drugs. A recent article reported that black enrollment is extremely low; limiting our understanding of how these drugs effect blacks...
Clinical trials lead to the approval of new drugs. A recent article reported that black enrollment is extremely low; limiting our understanding of how these drugs effect blacks...
One Two Punch could slow the spread of cancer
There is no one pathway, which controls prostate cancer growth, more clinical trials are being designed using more than one drug. This ONE TWO punch design could slow the spread of cancer.
There is no one pathway, which controls prostate cancer growth, more clinical trials are being designed using more than one drug. This ONE TWO punch design could slow the spread of cancer.
Shinta Cheng, MD, PhD
Executive Medical Director
Janssen Pharmaceuticals, Ltd.
actively recruiting prostate cancer clinical trials